We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+23.01%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.94B
AUM Growth
+$900M
Cap. Flow
+$775M
Cap. Flow %
39.93%
Top 10 Hldgs %
51.62%
Holding
194
New
73
Increased
41
Reduced
31
Closed
42

Top Buys

Rank Stock Value
1
COO icon
Cooper Companies
COO
+$24.5M
2
PPD
PPD, Inc. Common Stock
PPD
+$19M
3
OM icon
Outset Medical
OM
+$18.6M
4
AFIB
Acutus Medical Inc
AFIB
+$16.2M
5
VCEL icon
Vericel Corp
VCEL
+$14.9M

Top Sells

Rank Stock Value
1
LHCG
LHC Group LLC
LHCG
+$8.66M
2
INSP icon
Inspire Medical Systems
INSP
+$8.51M
3
LIVN icon
LivaNova
LIVN
+$7.29M
4
OSUR icon
OraSure Technologies
OSUR
+$6.64M
5
BSX icon
Boston Scientific
BSX
+$6.44M

Sector Composition

Rank Sector Weight
1 Healthcare 31.67%
2 Industrials 0.76%
3 Consumer Staples 0.45%
4 Energy 0.25%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNH icon
51
PUT
UnitedHealth
UNH
$364B
$7.79M 0.4%
25,000
-32,000
-56% -$9.83M
SRPT icon
52
CALL
Sarepta Therapeutics
SRPT
$1.94B
$7.58M 0.39%
54,000
+3,000
+6% +$456K
IRTC icon
53
PUT
iRhythm Holdings
IRTC
$4.13B
$7.14M 0.37%
30,000
+12,500
+71% +$2.21M
MRNA icon
54
CALL
Moderna
MRNA
$25.4B
$7.08M 0.36%
+100,000
New +$6.97M
VEEV icon
55
PUT
Veeva Systems
VEEV
$39.2B
$7.03M 0.36%
25,000
-36,000
-59% -$9.49M
HZNP
56
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$6.99M 0.36%
+90,000
New +$6.19M
SILK
57
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$6.95M 0.36%
103,400
-15,500
-13% -$846K
LSF icon
58
Laird Superfood
LSF
$46.8M
$6.88M 0.35%
+150,000
New +$6.49M
OTIC
59
DELISTED
Otonomy, Inc.
OTIC
$6.77M 0.35%
1,671,748
+424,890
+34% +$1.6M
TMO icon
60
PUT
Thermo Fisher Scientific
TMO
$223B
$6.62M 0.34%
+15,000
New +$6.2M
MMM icon
61
CALL
3M
MMM
$94.8B
$6.41M 0.33%
+47,840
New +$6.44M
PPH icon
62
PUT
VanEck Pharmaceutical ETF
PPH
$990M
$6.22M 0.32%
+100,000
New +$6.32M
TECH icon
63
PUT
Bio-Techne
TECH
$11.3B
$6.19M 0.32%
+100,000
New +$6.51M
LAB icon
64
Standard BioTools
LAB
$312M
$6.04M 0.31%
812,757
-31,543
-4% -$218K
BMY icon
65
CALL
Bristol-Myers Squibb
BMY
$130B
$6.03M 0.31%
100,000
-206,000
-67% -$12.4M
MSON
66
DELISTED
Misonix Inc
MSON
$5.75M 0.3%
490,586
+127,000
+35% +$1.65M
IMVT icon
67
Immunovant
IMVT
$8.8B
$5.6M 0.29%
159,026
-111,780
-41% -$3.36M
INOV
68
CALL
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$5.29M 0.27%
200,000
-156,600
-44% -$3.67M
NVTA
69
DELISTED
Invitae Corporation
NVTA
$5.29M 0.27%
122,000
-18,900
-13% -$645K
BMY icon
70
Bristol-Myers Squibb
BMY
$130B
$5.27M 0.27%
+87,469
New +$5.26M
SDGR icon
71
Schrodinger
SDGR
$1.39B
$5.11M 0.26%
+107,500
New +$7.39M
TFX icon
72
PUT
Teleflex
TFX
$6.03B
$5.11M 0.26%
+15,000
New +$5.56M
QTRX icon
73
Quanterix
QTRX
$139M
$5.1M 0.26%
+151,175
New +$4.87M
GKOS icon
74
CALL
Glaukos
GKOS
$11B
$4.95M 0.26%
+100,000
New +$4.39M
ABMD
75
PUT
DELISTED
Abiomed Inc
ABMD
$4.85M 0.25%
17,500
+2,500
+17% +$720K
1 2
3
4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2020 Portfolio in Review

As of Q3 2020, Pura Vida Investments held 194 positions worth $1.94B, up 87% from $1.04B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Pura Vida Investments deployed $775M of net new capital in Q3 2020, opening 73 new positions and adding to 41 existing holdings. Its largest new stake was Cooper Companies: 320,000 shares worth $27M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 38% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was LHC Group LLC, an estimated $8.66M trimmed.

  • Pura Vida Investments's largest Q3 2020 buy was Cooper Companies: 320,000 shares worth $27M.
  • Pura Vida Investments added most to Quotient Limited Ordinary Shares in Q3 2020, an estimated $11.6M increase.
  • Pura Vida Investments's biggest Q3 2020 reduction was LHC Group LLC, cutting an estimated $8.66M.
  • Pura Vida Investments fully exited LivaNova in Q3 2020, selling an estimated $7.29M.
  • Pura Vida Investments's ten largest holdings make up 52% of its $1.94B portfolio in Q3 2020.
  • Pura Vida Investments opened 73 new positions and closed 42 in Q3 2020.
  • Pura Vida Investments's portfolio value rose 87% quarter-over-quarter to $1.94B.

Based on Pura Vida Investments's 13F filing for Q3 2020, filed 16 Nov 2020.